10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$1.62B
Close$
$42.06
223.3% upside
Current Fair Value
223.3% upsideUndervalued by 223.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.62 Billion |
|---|---|
| Enterprise Value | $1.36 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.52 |
| Beta | 1.98 |
| Outstanding Shares | 122,606,091 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.16 |
|---|---|
| PEG | 23.79 |
| Price to Sales | 2.6 |
| Price to Book Ratio | 2.6 |
| Enterprise Value to Revenue | 2.17 |
| Enterprise Value to EBIT | -7.48 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov